- Funding will advance development of Rejuvenate’s one-time gene therapy RJB-0402 for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio ...
DIEPENBEEK, Belgium, May 19, 2025 (GLOBE NEWSWIRE) -- Rejuvenate Biomed, an AI-enabled, clinical-stage biotech company developing safe, synergistic combination therapeutics that alter the course of ...
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Rejuvenate Bio has secured an exclusive worldwide license from the Harvard Office of Technology ...
Fully recruited Phase 2 trial evaluates RJx-01 in older adults with COPD-induced muscle weakness and sarcopenia, an area with no approved pharmacologic treatments RJx-01 offers a multi-pathway ...
Voted Best Drink by leading U.S. and Canadian retail buyers in a head-to-head taste test against 30+ top CPG brands Available in over 8,000 retail locations plus Top 100 Protein Drink status on Amazon ...
SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio, today announced the appointment of Deborah Ascheim, M.D., as Chief Medical Officer. In this inaugural role, she will oversee clinical development and ...
Harvard Genetics Giant Geroge Church and Noah Davidsohn, a former postdoc in his lab, have engaged in a secretive antiaging venture called Rejuvenate Bio. They are making old dogs new. They have ...
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Rejuvenate Bio has secured an exclusive worldwide license from the Harvard Office of Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results